NDC 51808-214

Exametazime HMPAO

Exametazime

Exametazime HMPAO is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Exametazime.

• Product ID: 51808-214_dd2d8053-37a4-465d-9086-2bd084c4898c
• NDC: 51808-214
• Product Type: Human Prescription Drug
• Proprietary Name: Exametazime HMPAO
• Generic Name: Exametazime
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2012-07-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: AnazaoHealth Corporation
• Substance Name: EXAMETAZIME
• Active Ingredient Strength: 1 mg/1
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 51808-214-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-214-01)

• Marketing Start Date: 2012-07-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51808-214-01 [51808021401]

Exametazime HMPAO INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: Unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-07-01
• Inactivation Date: 2019-11-27

Drug Details

Active Ingredients

Ingredient	Strength
EXAMETAZIME	1 mg/1

OpenFDA Data

• SPL SET ID: 6ea1fd48-c649-4e05-856e-bb123ce40a3f
• Manufacturer:
  • AnazaoHealth Corporation
• UNII:
  • G29272NCKL

NDC Crossover Matching brand name "Exametazime HMPAO" or generic name "Exametazime"

NDC	Brand Name	Generic Name
17156-023	Ceretec	Exametazime
51808-214	Exametazime	Exametazime